- Philips Agrees to Buy Carestream’s Medical Imaging IT Business
- Precision Medical Imaging Market to Reach $8B by 2027, Says Frost
“How do you take knowledge? How do you apply it so that it doesn't sit in a few places in Children's Hospital, but you can literally make it so that no child going anywhere ends up with a misdiagnosis?” Boston Children’s Hospital CEO Sandra Fenwick was quoted by the BBJ as saying at a recent Boston Chamber of Commerce breakfast.
“That's one thing that we're working on that we really think is going to change the way children get care, not just at Children's but much more broadly,” Fenwick said.
In a recent study, Frost & Sullivan predicted that the precision medical imaging market would reach $8 billion by 2027, up from $120 million in 2017.
Precision medical imaging incorporates newer technologies, such as AI, deep learning, sensors, 3D printing, and clinical decision support software.
“Precision medical imaging has tremendous potential to improve all aspects of the care continuum, thus supporting emerging care approaches that are more targeted, predictive, translational, personalized and effective,” said Siddharth Saha, Frost & Sullivan VP of transformational health research.
“AI-enriched imaging equipment will help adapt and personalize the imaging protocols and procedures while precise radiomic and phenomic datasets from the given clinical context will enable deep learning, thereby reinforcing medical imaging's contribution to precision medicine," Saha noted.
"There are several firms in the ecosystem making very valuable contributions to the care pathways, and this pool is set to exponentially grow in the short term,” Saha commented.
These firms include GE Healthcare, Siemens Healthineers, and Philips Healthcare.
